| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Elevance Health, Inc. (ELV) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ELV is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 151.0K | $60.01M | - | |
| CFO | 16.1K | $6.39M | - | |
| Dir | 11.5K | $4.57M | - | |
| Dir | 10.3K | $4.10M | - | |
| Dir | 9.6K | $3.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2018 | Hill Julie A | Director | Sell | 500 | $287.25 | $143,625.00 | -1.4% | |
| Nov 7, 2018 | Zielinski Thomas C | EVP &General Counsel | Sale+OE | 7,826 | $289.71 | $2,267,270.46 | -23.1% | |
| Oct 31, 2018 | Haytaian Peter D | EVP &President, Commercial | Sell | 1,000 | $270.00 | $270,000.00 | -4.4% | |
| Oct 26, 2018 | Haytaian Peter D | EVP &President, Commercial | Sell | 3,500 | $267.59 | $936,570.00 | -3.5% | |
| Sep 27, 2018 | Haytaian Peter D | EVP &President, Commercial | Sell | 4,500 | $270.00 | $1,215,000.00 | -8.1% | |
| Sep 6, 2018 | Haytaian Peter D | EVP &President, Commercial | Sale+OE | 2,936 | $270.00 | $792,720.00 | -2.5% | |
| Sep 4, 2018 | Penczek Ronald W52 | SVP, Chief Accounting Officer | Sale+OE | 763 | $265.56 | $202,622.28 | -45.1% | |
| Aug 27, 2018 | Haytaian Peter D | EVP &President, Commercial | Sell | 3,500 | $265.92 | $930,724.40 | -3.0% | |
| Aug 16, 2018 | Hill Julie A | Director | Sell | 248 | $267.01 | $66,218.48 | -0.7% | |
| Jul 26, 2018 | Samitt Craig E | EVP &President, Dbg | Sale+OE | 19,541 | $246.68 | $4,820,373.88 | -53.1% |